James Joyce,
Chairman & CEO
Mr. Joyce is the founder, Chairman and Chief Executive Officer of Aethlon Medical, a publicly traded developer of immunotherapeutic technologies to combat infectious disease and cancer. Mr. Joyce is also the Executive Chairman of Exosome Sciences, a majority-owned subsidiary of Aethlon Medical that is focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
|
|
|
